261 related articles for article (PubMed ID: 33376242)
1. In-depth blood proteome profiling analysis revealed distinct functional characteristics of plasma proteins between severe and non-severe COVID-19 patients.
Park J; Kim H; Kim SY; Kim Y; Lee JS; Dan K; Seong MW; Han D
Sci Rep; 2020 Dec; 10(1):22418. PubMed ID: 33376242
[TBL] [Abstract][Full Text] [Related]
2. Plasma Gradient of Soluble Urokinase-Type Plasminogen Activator Receptor Is Linked to Pathogenic Plasma Proteome and Immune Transcriptome and Stratifies Outcomes in Severe COVID-19.
Sarif J; Raychaudhuri D; D'Rozario R; Bandopadhyay P; Singh P; Mehta P; Hoque MA; Sinha BP; Kushwaha M; Sahni S; Devi P; Chattopadhyay P; Paul SR; Ray Y; Chaudhuri K; Banerjee S; Majumdar D; Saha B; Sarkar BS; Bhattacharya P; Chatterjee S; Paul S; Ghosh P; Pandey R; Sengupta S; Ganguly D
Front Immunol; 2021; 12():738093. PubMed ID: 34777349
[TBL] [Abstract][Full Text] [Related]
3. Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality.
Alosaimi B; Mubarak A; Hamed ME; Almutairi AZ; Alrashed AA; AlJuryyan A; Enani M; Alenzi FQ; Alturaiki W
Front Immunol; 2021; 12():668725. PubMed ID: 34276659
[TBL] [Abstract][Full Text] [Related]
4. Proteomics of serum-derived extracellular vesicles are associated with the severity and different clinical profiles of patients with COVID-19: An exploratory secondary analysis.
Paes Leme AF; Yokoo S; Normando AGC; Ormonde JVS; Domingues RR; Cruz FF; Silva PL; Souza BSF; Dos Santos CC; Castro-Faria-Neto H; Martins CM; Lopes-Pacheco M; Rocco PRM
Cytotherapy; 2024 May; 26(5):444-455. PubMed ID: 38363248
[TBL] [Abstract][Full Text] [Related]
5. Proteome-wide Mendelian randomization identifies causal links between blood proteins and severe COVID-19.
Palmos AB; Millischer V; Menon DK; Nicholson TR; Taams LS; Michael B; Sunderland G; Griffiths MJ; ; Hübel C; Breen G
PLoS Genet; 2022 Mar; 18(3):e1010042. PubMed ID: 35239653
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death.
Gisby J; Clarke CL; Medjeral-Thomas N; Malik TH; Papadaki A; Mortimer PM; Buang NB; Lewis S; Pereira M; Toulza F; Fagnano E; Mawhin MA; Dutton EE; Tapeng L; Richard AC; Kirk PD; Behmoaras J; Sandhu E; McAdoo SP; Prendecki MF; Pickering MC; Botto M; Willicombe M; Thomas DC; Peters JE
Elife; 2021 Mar; 10():. PubMed ID: 33704068
[TBL] [Abstract][Full Text] [Related]
7. A specific low-density neutrophil population correlates with hypercoagulation and disease severity in hospitalized COVID-19 patients.
Morrissey SM; Geller AE; Hu X; Tieri D; Ding C; Klaes CK; Cooke EA; Woeste MR; Martin ZC; Chen O; Bush SE; Zhang HG; Cavallazzi R; Clifford SP; Chen J; Ghare S; Barve SS; Cai L; Kong M; Rouchka EC; McLeish KR; Uriarte SM; Watson CT; Huang J; Yan J
JCI Insight; 2021 May; 6(9):. PubMed ID: 33986193
[TBL] [Abstract][Full Text] [Related]
8. Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications.
Al-Nesf MAY; Abdesselem HB; Bensmail I; Ibrahim S; Saeed WAH; Mohammed SSI; Razok A; Alhussain H; Aly RMA; Al Maslamani M; Ouararhni K; Khatib MY; Hssain AA; Omrani AS; Al-Kaabi S; Al Khal A; Al-Thani AA; Samsam W; Farooq A; Al-Suwaidi J; Al-Maadheed M; Al-Siddiqi HH; Butler AE; Decock JV; Mohamed-Ali V; Al-Ejeh F
Nat Commun; 2022 Feb; 13(1):946. PubMed ID: 35177642
[TBL] [Abstract][Full Text] [Related]
9. Plasma proteomics identify potential severity biomarkers from COVID-19 associated network.
Sahin AT; Yurtseven A; Dadmand S; Ozcan G; Akarlar BA; Kucuk NEO; Senturk A; Ergonul O; Can F; Tuncbag N; Ozlu N
Proteomics Clin Appl; 2023 Mar; 17(2):e2200070. PubMed ID: 36217943
[TBL] [Abstract][Full Text] [Related]
10. Immunity and coagulation and fibrinolytic processes may reduce the risk of severe illness in pregnant women with coronavirus disease 2019.
Zhong Y; Cao Y; Zhong X; Peng Z; Jiang S; Tang T; Chen H; Li X; Xia Y; Cheng Y; Zhao X
Am J Obstet Gynecol; 2021 Apr; 224(4):393.e1-393.e25. PubMed ID: 33098813
[TBL] [Abstract][Full Text] [Related]
11. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
Front Immunol; 2021; 12():700921. PubMed ID: 34539631
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal plasma proteomic analysis of 1117 hospitalized patients with COVID-19 identifies features associated with severity and outcomes.
Viode A; Smolen KK; van Zalm P; Stevenson D; Jha M; Parker K; ; Levy O; Steen JA; Steen H
Sci Adv; 2024 May; 10(21):eadl5762. PubMed ID: 38787940
[TBL] [Abstract][Full Text] [Related]
13. Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection.
Horspool AM; Kieffer T; Russ BP; DeJong MA; Wolf MA; Karakiozis JM; Hickey BJ; Fagone P; Tacker DH; Bevere JR; Martinez I; Barbier M; Perrotta PL; Damron FH
mSphere; 2021 Jan; 6(1):. PubMed ID: 33472985
[TBL] [Abstract][Full Text] [Related]
14. Plasma Proteins Associated with COVID-19 Severity in Puerto Rico.
Rosario-Rodríguez LJ; Cantres-Rosario YM; Carrasquillo-Carrión K; Rosa-Díaz A; Rodríguez-De Jesús AE; Rivera-Nieves V; Tosado-Rodríguez EL; Méndez LB; Roche-Lima A; Bertrán J; Meléndez LM
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791465
[TBL] [Abstract][Full Text] [Related]
15. Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptoms.
Zhong W; Altay O; Arif M; Edfors F; Doganay L; Mardinoglu A; Uhlen M; Fagerberg L
EBioMedicine; 2021 Dec; 74():103723. PubMed ID: 34844191
[TBL] [Abstract][Full Text] [Related]
16. Temporal dynamics of the host molecular responses underlying severe COVID-19 progression and disease resolution.
Ong EZ; Kalimuddin S; Chia WC; Ooi SH; Koh CW; Tan HC; Zhang SL; Low JG; Ooi EE; Chan KR
EBioMedicine; 2021 Mar; 65():103262. PubMed ID: 33691247
[TBL] [Abstract][Full Text] [Related]
17. A blood atlas of COVID-19 defines hallmarks of disease severity and specificity.
;
Cell; 2022 Mar; 185(5):916-938.e58. PubMed ID: 35216673
[TBL] [Abstract][Full Text] [Related]
18. Complement C5a and Clinical Markers as Predictors of COVID-19 Disease Severity and Mortality in a Multi-Ethnic Population.
Cyprian FS; Suleman M; Abdelhafez I; Doudin A; Masud Danjuma M; Mir FA; Parray A; Yousaf Z; Siddiqui MYA; Abdelmajid A; Mulhim M; Al-Shokri S; Abukhattab M; Shaheen R; Elkord E; Al-Khal AL; Elzouki AN; Girardi G
Front Immunol; 2021; 12():707159. PubMed ID: 34966381
[TBL] [Abstract][Full Text] [Related]
19. Association of Neutrophil Activation, More Than Platelet Activation, With Thrombotic Complications in Coronavirus Disease 2019.
Petito E; Falcinelli E; Paliani U; Cesari E; Vaudo G; Sebastiano M; Cerotto V; Guglielmini G; Gori F; Malvestiti M; Becattini C; Paciullo F; De Robertis E; Bury L; Lazzarini T; Gresele P;
J Infect Dis; 2021 Mar; 223(6):933-944. PubMed ID: 33280009
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-8 as a Biomarker for Disease Prognosis of Coronavirus Disease-2019 Patients.
Li L; Li J; Gao M; Fan H; Wang Y; Xu X; Chen C; Liu J; Kim J; Aliyari R; Zhang J; Jin Y; Li X; Ma F; Shi M; Cheng G; Yang H
Front Immunol; 2020; 11():602395. PubMed ID: 33488599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
